BAIT

BRCA1

BRCAI, BRCC1, BROVCA1, FANCS, IRIS, PNCA4, PPP1R53, PSCP, RNF53
breast cancer 1, early onset
GO Process (44)
GO Function (10)
GO Component (11)

Gene Ontology Biological Process

Homo sapiens
PREY

IL22RA2

CRF2-10, CRF2-S1, CRF2X, IL-22BP, IL-22R-alpha-2, IL-22RA2, ZCYTOR16, UNQ5793/PRO19598/PRO19822
interleukin 22 receptor, alpha 2
GO Process (2)
GO Function (2)
GO Component (3)
Homo sapiens

Negative Genetic

Mutations/deletions in separate genes, each of which alone causes a minimal phenotype, but when combined in the same cell results in a more severe fitness defect or lethality under a given condition. This term is reserved for high or low throughput studies with scores.

Publication

Network-Based Combinatorial CRISPR-Cas9 Screens Identify Synergistic Modules in Human Cells.

Guo Y, Bao C, Ma D, Cao Y, Li Y, Xie Z, Li S

Tumorigenesis is a complex process that is driven by a combination of networks of genes and environmental factors; however, efficient approaches to identifying functional networks that are perturbed by the process of tumorigenesis are lacking. In this study, we provide a comprehensive network-based strategy for the systematic discovery of functional synergistic modules that are causal determinants of inflammation-induced tumorigenesis. Our ... [more]

ACS Synth Biol Dec. 15, 2018; 8(3);482-490 [Pubmed: 30762338]

Throughput

  • Low Throughput

Ontology Terms

  • phenotype: viability (PATO:0000169)
  • phenotype: growth abnormality (HP:0001507)

Additional Notes

  • CRISPR GI screen
  • Cell Line:NCM460 cells
  • Experimental Setup: Cytokine Exposure (TGFB1)
  • GIST: A-phenotypic negative genetic interaction
  • Library: Targeted Library
  • Significance Threshold: dGI < -0.84

Curated By

  • BioGRID